federal_register: E9-265
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E9-265 | Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets and Boluses | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by First Priority, Inc. The supplemental application provides for revising the description of a 1-gram oral dosage form of phenylbutazone from tablet to bolus. | 2009-01-12 | 2009 | 1 | https://www.federalregister.gov/documents/2009/01/12/E9-265/oral-dosage-form-new-animal-drugs-phenylbutazone-tablets-and-boluses | https://www.govinfo.gov/content/pkg/FR-2009-01-12/pdf/E9-265.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by First Priority, Inc. The supplemental application provides for revising the description of... |